Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant.

Anugwom, Chimaobi M; Leventhal, Thomas M; Debes, Jose D

Anugwom, Chimaobi M; Leventhal, Thomas M; Debes, Jose D.

Afiliação

Anugwom CM; HealthPartners Digestive Care, Saint Paul, Minnesota, MN 55130, USA.
Leventhal TM; Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition and Division of Infectious Disease and International Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Debes JD; Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition and Division of Infectious Disease and International Medicine, University of Minnesota, Minneapolis, MN 55455, USA.

Hepatoma Res ; 82022.

Article em En | MEDLINE | ID: mdl-35693455

Palavras-chave

Hepatocellular carcinoma; checkpoint inhibitors; liver transplant

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Hepatoma Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google